Research, Select, & Monitor Sunday, September 20, 2020 3:25:41 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Recro Pharma, Inc$2.48$.145.98%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Recro Pharma, Inc vs Chemicals - Major Diversified

Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $99.2 Mil $152,519.5 Mil
  Market Cap: $58.5 Mil $325,073.8 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: 28.3% (13.7%)
  Estimated Revenue: (25.1%) (3.3%)
  Historic Earnings: N/A (6.7%)
  Estimated Earnings: (200.0%) 6.3%
  Stock Price (1 Year): (78.8%) 8.3%
  Cash per Share: (53.0%) (2.6%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 19.0
  Price-to-Sales: .6 N/A
  Price-to-Book: (8.4) 3.4
  Dividend Yield: N/A N/A
  Market Cap: $58.5 Mil $32,507.4 Mil
  Net Margin: (18.8%) 11.7%
  Gross Margin: 48.6% 35.1%
  Return on Equity: N/A .1
  Return on Assets: (.2) .0
  Balance Sheet
  Current Ratio: 9.3 1.6
  Quick Ratio: 6.9 1.1
  Cash Ratio: 3.0 .3
  Debt-to-Equity: N/A 1.8
  Interest Coverage: .0 .5
  Relative-Strength Index: 36.2 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $33.07 $77,927.5 Mil
  Air Products & Chemicals, Inc.  (APD) $295.81 $65,788.1 Mil
  Du Pont De Nemours & Co., Inc.  (DD) $59.29 $43,536.6 Mil
  Henkel KGaA  (HENKY) $22.75 $39,854.1 Mil
  Dow Chemical Co.  (DOW) $50.37 $37,238.5 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.